REGENXBIO Inc. (RGNX) › Net IncomeREGENXBIO Inc. (RGNX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2013: -$5.39M2014: -$4.00M2015: -$22.81M2016: -$62.97M2017: -$73.17M2018: $99.94M2019: -$94.73M2020: -$111.25M2021: $127.84M2022: -$280.32M2023: -$263.49M2024: -$227.10M2025: -$193.88M-$193.88M2013Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$193.88M+14.6%2024-$227.10M+13.8%2023-$263.49M+6.0%2022-$280.32M-319.3%2021$127.84M+214.9%2020-$111.25M-17.4%2019-$94.73M-194.8%2018$99.94M+236.6%2017-$73.17M-16.2%2016-$62.97M-176.0%2015-$22.81M-469.8%2014-$4.00M+25.7%2013-$5.39M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share